Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Carcinoma, Basal Cell 4Chalazion 2Bone Neoplasms 2Recurrence 1Pilonidal Sinus 1Pain 1Keratosis, Actinic 1Giant Cell Tumors 1Giant Cell Tumor of Bone 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Chondrosarcoma 1Chondroma 1Carcinoma, Squamous Cell 1Bone Cysts 1

Interventions

Cyclophosphamide 115Dexamethasone 70fludarabine phosphate 57Cytarabine 56fludarabine 52Rituximab 51Peripheral Blood Stem Cell Transplantation 40Etoposide 40Gemcitabine 39Lenalidomide 38pembrolizumab 33Radiotherapy 33Busulfan 33Filgrastim 32Carboplatin 31Methotrexate 30Cyclosporine 29Cisplatin 29Bortezomib 29Mycophenolic Acid 28Melphalan 28venetoclax 27Paclitaxel 26Whole-Body Irradiation 24Antilymphocyte Serum 23Temozolomide 22Granulocyte Colony-Stimulating Factor 20Calcium Dobesilate 20Bevacizumab 20Tacrolimus 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Recurrence × Curettage × Clear all
NCT00515970 2010-06-15

Curettage Versus Excision in Nodular and Superficial Basal Cell Carcinomas

University Hospital Tuebingen

Phase NA Suspended
400 enrolled
Dermatologic

Carcinoma, Basal Cell, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡